Beijing Leadman Biochemistry Co Ltd (300289) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.007x

Based on the latest financial reports, Beijing Leadman Biochemistry Co Ltd (300289) has a cash flow conversion efficiency ratio of 0.007x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥11.89 Million ≈ $1.74 Million USD) by net assets (CN¥1.71 Billion ≈ $250.60 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Beijing Leadman Biochemistry Co Ltd - Cash Flow Conversion Efficiency Trend (2008–2024)

This chart illustrates how Beijing Leadman Biochemistry Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read how much debt does Beijing Leadman Biochemistry Co Ltd carry for a breakdown of total debt and financial obligations.

Beijing Leadman Biochemistry Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Beijing Leadman Biochemistry Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Ennis Inc NYSE:EBF	0.054x
Ur Energy Inc NYSE MKT:URG	-0.166x
Surfilter Network Technology Co Ltd SHE:300311	0.008x
Hefei Taihe Optoelectronic SHG:603656	0.052x
Beijing Shengtong Printing Co Ltd SHE:002599	0.039x
Lanzhou Greatwall Electrical Co Ltd SHG:600192	-0.019x
PKU HealthCare Corp Ltd SHE:000788	0.070x
Guangdong TianYiMa Information Industry Co.Ltd. SHE:301178	N/A

Annual Cash Flow Conversion Efficiency for Beijing Leadman Biochemistry Co Ltd (2008–2024)

The table below shows the annual cash flow conversion efficiency of Beijing Leadman Biochemistry Co Ltd from 2008 to 2024. For the full company profile with market capitalisation and key ratios, see 300289 stock market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥1.72 Billion ≈ $251.48 Million	CN¥62.41 Million ≈ $9.13 Million	0.036x	-51.25%
2023-12-31	CN¥1.80 Billion ≈ $264.07 Million	CN¥134.42 Million ≈ $19.67 Million	0.074x	+21.74%
2022-12-31	CN¥1.78 Billion ≈ $260.54 Million	CN¥108.93 Million ≈ $15.94 Million	0.061x	+1.65%
2021-12-31	CN¥1.98 Billion ≈ $289.46 Million	CN¥119.06 Million ≈ $17.42 Million	0.060x	-38.79%
2020-12-31	CN¥1.38 Billion ≈ $201.75 Million	CN¥135.56 Million ≈ $19.84 Million	0.098x	+14.38%
2019-12-31	CN¥1.45 Billion ≈ $212.18 Million	CN¥124.65 Million ≈ $18.24 Million	0.086x	+52.52%
2018-12-31	CN¥1.44 Billion ≈ $210.34 Million	CN¥81.02 Million ≈ $11.86 Million	0.056x	-33.59%
2017-12-31	CN¥1.43 Billion ≈ $208.55 Million	CN¥120.97 Million ≈ $17.70 Million	0.085x	+38.74%
2016-12-31	CN¥1.34 Billion ≈ $195.60 Million	CN¥81.78 Million ≈ $11.97 Million	0.061x	-56.65%
2015-12-31	CN¥1.26 Billion ≈ $184.37 Million	CN¥177.82 Million ≈ $26.02 Million	0.141x	+1267.55%
2014-12-31	CN¥1.09 Billion ≈ $159.89 Million	CN¥-13.21 Million ≈ $-1.93 Million	-0.012x	-111.38%
2013-12-31	CN¥851.12 Million ≈ $124.55 Million	CN¥90.45 Million ≈ $13.24 Million	0.106x	+39.78%
2012-12-31	CN¥761.02 Million ≈ $111.36 Million	CN¥57.86 Million ≈ $8.47 Million	0.076x	-42.81%
2011-12-31	CN¥220.77 Million ≈ $32.31 Million	CN¥29.34 Million ≈ $4.29 Million	0.133x	-60.29%
2010-12-31	CN¥159.72 Million ≈ $23.37 Million	CN¥53.46 Million ≈ $7.82 Million	0.335x	+12.77%
2009-12-31	CN¥105.32 Million ≈ $15.41 Million	CN¥31.26 Million ≈ $4.57 Million	0.297x	+13.30%
2008-12-31	CN¥83.90 Million ≈ $12.28 Million	CN¥21.98 Million ≈ $3.22 Million	0.262x	--

About Beijing Leadman Biochemistry Co Ltd

SHE:300289 China Medical Devices

Market Cap

$534.16 Million

CN¥3.65 Billion CNY

Market Cap Rank

#12204 Global

#3768 in China

Share Price

CN¥6.71

Change (1 day)

-0.74%

52-Week Range

CN¥4.73 - CN¥11.33

All Time High

CN¥23.05